Treatment of Tourette's syndrome with haloperidol, review of 34 cases.
D000293:Adolescent; D000328:Adult; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D002648:Child; D003863:Depression / Q000139:chemically induced; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D006220:Haloperidol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000139:chemically induced; D011613:Psychotherapy; D013997:Time Factors; D005879:Tourette Syndrome / Q000188:drug therapy* / Q000628:therapy
D006220:Haloperidol